Free Chat Friday (Every Friday) -- Our live chat room with stock and option alerts! Fridays, starting at 9:30 am, go to: https://goo.gl/O3l5KC use the password: freechatfriday

Prosensa Holding NV
(NASDAQ : RNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading RNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.52%69.731.0%$927.54m
AMGNAmgen Inc.
-0.40%173.320.8%$651.38m
BIIBBiogen Inc.
-0.62%283.000.9%$511.27m
CELGCelgene Corporation
-1.49%117.691.0%$481.10m
REGNRegeneron Pharmaceuticals, Inc.
-1.24%356.471.9%$332.28m
ALXNAlexion Pharmaceuticals, Inc.
-0.21%130.172.0%$299.58m
TSROTESARO, Inc.
-0.23%185.5115.3%$193.03m
INCYIncyte Corporation
5.36%128.492.3%$174.44m
ILMNIllumina, Inc.
-0.93%159.523.9%$139.83m
VRTXVertex Pharmaceuticals Incorporated
-0.57%85.242.6%$136.66m
CLVSClovis Oncology, Inc.
0.36%57.9216.4%$126.21m
EXELExelixis, Inc.
-0.71%21.595.5%$123.93m
AAgilent Technologies, Inc.
0.29%51.621.7%$112.71m
ACADACADIA Pharmaceuticals Inc.
-1.80%38.8519.0%$94.25m
BMRNBioMarin Pharmaceutical Inc.
-2.87%86.734.0%$88.81m

Company Profile

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.